CA2442012A1 - Derives chimiques et leur application comme agent antitelomerase - Google Patents
Derives chimiques et leur application comme agent antitelomerase Download PDFInfo
- Publication number
- CA2442012A1 CA2442012A1 CA002442012A CA2442012A CA2442012A1 CA 2442012 A1 CA2442012 A1 CA 2442012A1 CA 002442012 A CA002442012 A CA 002442012A CA 2442012 A CA2442012 A CA 2442012A CA 2442012 A1 CA2442012 A1 CA 2442012A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- radical
- amino
- optionally substituted
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0103916A FR2822468B1 (fr) | 2001-03-23 | 2001-03-23 | Derives chimiques et leur application comme agent anti-telomerase |
| FR01/03916 | 2001-03-23 | ||
| FR01/10370 | 2001-08-02 | ||
| FR0110370 | 2001-08-02 | ||
| PCT/FR2002/001005 WO2002076975A1 (fr) | 2001-03-23 | 2002-03-22 | Derives chimiques et leur application comme agent antitelomerase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2442012A1 true CA2442012A1 (fr) | 2002-10-03 |
Family
ID=26212933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002442012A Abandoned CA2442012A1 (fr) | 2001-03-23 | 2002-03-22 | Derives chimiques et leur application comme agent antitelomerase |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1373252A1 (https=) |
| JP (1) | JP2004524349A (https=) |
| AR (1) | AR034297A1 (https=) |
| AU (1) | AU2002251140B2 (https=) |
| CA (1) | CA2442012A1 (https=) |
| CO (1) | CO5380035A1 (https=) |
| IL (2) | IL158056A0 (https=) |
| MX (1) | MXPA03008269A (https=) |
| MY (1) | MY130957A (https=) |
| PE (1) | PE20020959A1 (https=) |
| WO (1) | WO2002076975A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002096903A2 (fr) | 2001-05-28 | 2002-12-05 | Aventis Pharma S.A. | Derives chimiques et leur application comme agent antitelomerase |
| US7173032B2 (en) * | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| AU2002361846A1 (en) * | 2001-12-21 | 2003-07-15 | Bayer Pharmaceuticals Corporation | Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| AU2003253735A1 (en) * | 2002-06-25 | 2004-01-06 | The Center For Blood Research, Inc. | Vacuolins |
| FR2850970B1 (fr) * | 2003-02-07 | 2006-07-07 | Aventis Pharma Sa | Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| NZ544472A (en) | 2003-07-03 | 2009-04-30 | Myriad Genetics Inc | Compounds and therapeutical use thereof |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| JP2008540585A (ja) * | 2005-05-19 | 2008-11-20 | プロメティック・バイオサイエンスィズ・インコーポレーテッド | 転移性メラノーマ及び他の癌を治療するための化合物、そのような化合物を含有する組成物、および治療方法 |
| EP2046763A2 (en) * | 2006-07-31 | 2009-04-15 | Praecis Pharmaceuticals Incorporated | Aurora kinase inhibitors from an encoded small molecule library |
| KR20100038108A (ko) * | 2007-07-25 | 2010-04-12 | 브리스톨-마이어스 스큅 컴퍼니 | 트리아진 키나제 억제제 |
| FR2948686B1 (fr) * | 2009-07-30 | 2011-08-19 | Biomerieux Sa | Nouveaux substrats de peptidase |
| WO2019181714A1 (ja) * | 2018-03-20 | 2019-09-26 | 国立大学法人広島大学 | テロメア結合タンパク質を阻害する化合物、及びそれを含むテロメア結合タンパク質阻害剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
| JPH1160573A (ja) * | 1997-08-22 | 1999-03-02 | Nippon Kayaku Co Ltd | トリアジン誘導体及びテロメラーゼ阻害剤 |
| US6262053B1 (en) * | 1999-06-23 | 2001-07-17 | Parker Hughes Institute | Melamine derivatives as potent anti-cancer agents |
| SK7402002A3 (en) * | 1999-11-29 | 2002-11-06 | Aventis Pharma Sa | Arylamine derivatives and their use as anti-telomerase agent |
| KR100875362B1 (ko) * | 2002-02-05 | 2008-12-22 | 아스텔라스세이야쿠 가부시키가이샤 | 2,4,6-트리아미노-1,3,5-트리아진 유도체 |
-
2002
- 2002-03-21 CO CO02025874A patent/CO5380035A1/es not_active Application Discontinuation
- 2002-03-22 PE PE2002000227A patent/PE20020959A1/es not_active Application Discontinuation
- 2002-03-22 AR ARP020101060A patent/AR034297A1/es unknown
- 2002-03-22 EP EP02720068A patent/EP1373252A1/fr not_active Withdrawn
- 2002-03-22 MY MYPI20021036A patent/MY130957A/en unknown
- 2002-03-22 AU AU2002251140A patent/AU2002251140B2/en not_active Ceased
- 2002-03-22 MX MXPA03008269A patent/MXPA03008269A/es not_active Application Discontinuation
- 2002-03-22 IL IL15805602A patent/IL158056A0/xx unknown
- 2002-03-22 JP JP2002576233A patent/JP2004524349A/ja not_active Ceased
- 2002-03-22 WO PCT/FR2002/001005 patent/WO2002076975A1/fr not_active Ceased
- 2002-03-22 CA CA002442012A patent/CA2442012A1/fr not_active Abandoned
-
2003
- 2003-09-22 IL IL158056A patent/IL158056A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1373252A1 (fr) | 2004-01-02 |
| WO2002076975A1 (fr) | 2002-10-03 |
| PE20020959A1 (es) | 2002-12-17 |
| MXPA03008269A (es) | 2004-10-15 |
| AR034297A1 (es) | 2004-02-18 |
| MY130957A (en) | 2007-07-31 |
| JP2004524349A (ja) | 2004-08-12 |
| IL158056A (en) | 2010-02-17 |
| AU2002251140B2 (en) | 2007-03-15 |
| CO5380035A1 (es) | 2004-03-31 |
| IL158056A0 (en) | 2004-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7240784B2 (ja) | ８，９－ジヒドロイミダゾール［１，２－ａ］ピリミド［５，４－ｅ］ピリミジン－５（６Ｈ）－ケトン類化合物 | |
| JP6846574B2 (ja) | スルホンアミド化合物およびその使用 | |
| JP5739820B2 (ja) | 置換５，６−ジヒドロ−６−フェニルベンゾ［ｆ］イソキノリン−２−アミン化合物 | |
| EP1244650B1 (fr) | Derives arylamines et leur application comme agent antitelomerase | |
| JP7121660B2 (ja) | 癌を処置するためのｅｚｈ２阻害剤の使用 | |
| KR20220092920A (ko) | 헬리오스의 소분자 분해제 및 사용 방법 | |
| JP2017190337A (ja) | がんを処置するための組合せ治療 | |
| CN107635965A (zh) | 用于治疗淋巴瘤的ezh2抑制剂 | |
| CA2442012A1 (fr) | Derives chimiques et leur application comme agent antitelomerase | |
| CN111566095A (zh) | 被取代的吡咯并吡啶jak抑制剂及其制造方法和使用方法 | |
| HUE034807T2 (en) | New quinoline-substituted compound | |
| CA2973773A1 (en) | 2-phenyl-3h-imidazo[4,5-b]pyridine derivatives useful as inhibitors of mammalian tyrosine kinase ror1 activity | |
| CN106715435A (zh) | 作为nr2b nmda受体拮抗剂的吡咯并嘧啶衍生物 | |
| CN115043817A (zh) | Sos1蛋白水解调节剂及其制备方法和应用 | |
| AU2022224918A1 (en) | Novel pyrazole derivatives | |
| FR2850970A1 (fr) | Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique | |
| CN118019743A (zh) | 可用作shp2抑制剂的化合物及其制备方法和用途 | |
| CN114206864B (zh) | 喹唑啉-2.4-二酮衍生物作为parp抑制剂 | |
| JPH0753376A (ja) | 強迫疾患の治療用医薬を製造するためのｎ−（ピリジニル）−１ｈ−インドール−１−アミンの使用 | |
| KR20240009422A (ko) | Sting 시그널링의 소분자 억제제 조성물 및 사용 방법 | |
| AU2018379438A1 (en) | Imidazopyridine derivatives and the use thereof as medicament | |
| EP3750893A1 (en) | Dioxazoline compound, preparation method therefor, and uses thereof | |
| CN110862398B (zh) | 脲取代的芳环连二噁烷并喹唑啉或喹啉类化合物、组合物及其应用 | |
| CA2433723A1 (fr) | Derives chimiques et leur application comme agent antitelomerase | |
| FR2822468A1 (fr) | Derives chimiques et leur application comme agent anti-telomerase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |